Clinical Trial Update: AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 1/2 study of AEE788 in combination with everolimus for patients with recurrent or relapsed glioblastoma multiforme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• AEE788
• Everolimus (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED